These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34061690)

  • 21. Asenapine: an atypical antipsychotic with atypical formulations.
    Musselman M; Faden J; Citrome L
    Ther Adv Psychopharmacol; 2021; 11():20451253211035269. PubMed ID: 34540197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential Formulation of Second Generation Antipsychotic Asenapine as Inclusion Complex with Sulphobutylether-βCD (Captisol): In vitro and In vivo Evaluation.
    Kulkarni JA; Avachat AM; Avachat CM; Pradhan R; Suryawanshi TS; Khan EM; Martis EAF; Coutinho EC; Padhye S
    Curr Drug Deliv; 2018; 15(4):520-531. PubMed ID: 29165075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability.
    Kulkarni JA; Avachat AM
    Drug Dev Ind Pharm; 2017 Feb; 43(2):234-245. PubMed ID: 27625143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asenapine for the treatment of bipolar disorder.
    Marazziti D; Mucci F; Falaschi V; Dell'Osso L
    Expert Opin Pharmacother; 2019 Aug; 20(11):1321-1330. PubMed ID: 31132287
    [No Abstract]   [Full Text] [Related]  

  • 25. The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.
    Tarazi FI; Neill JC
    Expert Opin Drug Discov; 2013 Jan; 8(1):93-103. PubMed ID: 23121334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases.
    Zhai J; Wang YE; Zhou X; Ma Y; Guan S
    Drug Deliv; 2020 Dec; 27(1):1283-1291. PubMed ID: 32885707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asenapine.
    Weber J; McCormack PL
    CNS Drugs; 2009 Sep; 23(9):781-92. PubMed ID: 19689168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-pot reaction for determination of Asenapine maleate through facile complex formation with xanthine based dye: Application to content uniformity test.
    Abu-Hassan AA; Ali R; Derayea SM
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Oct; 239():118474. PubMed ID: 32450539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asenapine pharmacokinetics and tolerability in a pediatric population.
    Dogterom P; Riesenberg R; de Greef R; Dennie J; Johnson M; Pilla Reddy V; Miltenburg AM; Findling RL; Jakate A; Carrothers TJ; Troyer MD
    Drug Des Devel Ther; 2018; 12():2677-2693. PubMed ID: 30214156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Asenapine Versus Olanzapine in Combination With Divalproex for Acute Mania: A Randomized Controlled Trial.
    Mahajan V; Arora M; Tandon VR; Gillani Z; Praharaj SK
    J Clin Psychopharmacol; 2019; 39(4):305-311. PubMed ID: 31205195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Nov; 11(7):673-86. PubMed ID: 19839993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.
    Dell'Osso B; Cremaschi L; Palazzo MC; Spagnolin G; Cattaneo A; Grancini B; Maggi M; Altamura AC
    Expert Opin Drug Saf; 2014 Sep; 13(9):1199-208. PubMed ID: 25084462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
    Landbloom RL; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
    J Affect Disord; 2016 Jan; 190():103-110. PubMed ID: 26496015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
    Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
    Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asenapine Transdermal Patch for the Management of Schizophrenia.
    Zhou M; Derakhshanian S; Rath A; Bertrand S; DeGraw C; Barlow R; Menard A; Kaye AM; Hasoon J; Cornett EM; Kaye AD; Viswanath O; Urits I
    Psychopharmacol Bull; 2020 Sep; 50(4):60-82. PubMed ID: 33012873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of Asenapine in the Treatment of Bipolar Disorder.
    Vieta E; Montes JM
    Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada.
    Lachaine J; Beauchemin C; Mathurin K; Gilbert D; Beillat M
    BMC Psychiatry; 2014 Jan; 14():16. PubMed ID: 24450548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.